HomepageEarnings Events Newsdesk 1 day ago Regeneron Pharmaceuticals Inc (REGN) Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Other Release TransDigm Group Incorporated (TDG) Sec Form 8K » « Hasbro, Inc. (HAS) Q4 2024 Earnings Results Newsdesk: